Table 3.
|
Fluoxetine alone |
CBT alone |
Combination (CBT + fluoxetine) |
Pill placebo |
||||
---|---|---|---|---|---|---|---|---|
Youth with ADHD n = 14 | Without ADHD n = 95 | Youth with ADHD n = 14 | Without ADHD n = 97 | Youth with ADHD n = 15 | Without ADHD n = 92 | Youth with ADHD n = 19 | Without ADHD n = 93 | |
Baseline | 56.08 ± 3.93 | 59.36 ± 4.24 | 60.01 ± 4.66 | 59.59 ± 4.78 | 58.59 ± 7.33 | 61.14 ± 4.78 | 55.55 ± 4.50 | 62.33 ± 4.43 |
Week 6 | 37.05 ± 6.03 | 40.37 ± 7.33 | 39.45 ± 5.68 | 44.98 ± 8.22 | 40.73 ± 8.54 | 37.58 ± 7.67 | 45.25 ± 5.30 | 44.59 ± 7.42 |
Week 12 | 33.29 ± 6.42 | 36.83 ± 8.11 | 35.95 ± 6.34 | 42.35 ± 8.96 | 37.08 ± 9.42 | 33.30 ± 8.14 | 43.31 ± 5.65 | 41.39 ± 8.07 |
Mean adjusted scores derived from the subgroup analyses.
Abbreviations: CDRS-R = Children's Depression Rating Scale–Revised; ADHD = attention-deficit/hyperactivity disorder; CBT = cognitive–behavioral therapy.